ONEGLOBAL

ONEGLOBAL · NSE

— · —

₹534.15

Closing price — 29 Sept 2026

Market cap ₹1,044 Cr · EPS ₹37.88

Valuation

Blended fair value using DCF and peer comparison methods.

See if ONEGLOBAL is undervalued

Unlock intrinsic value for 4,800+ Indian stocks — free.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Healthcare · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
ONEGLOBAL ONEGLOBAL · you	₹1,044 Cr	14.1×	56.6×	—	401.3%	0.1%	—
Sector median	—	43.8×	5.5×	22.9×	10.1%	6.5%	14.5%
Healthcare Global Enterprises Limited HCG	₹8,780 Cr	638.1×	6.6×	21.3×	1.0%	0.5%	14.5%
Sanofi India Limited SANOFI	₹7,249 Cr	45.1×	28.2×	23.0×	62.5%	27.3%	—
Nephrocare Health Services Limited NEPHROPLUS	₹6,944 Cr	83.4×	6.1×	28.8×	6.9%	7.7%	31.7%
Senores Pharmaceuticals Limited SENORES	₹6,803 Cr	365.6×	—	—	—	0.0%	—
FDC Limited FDC	₹5,781 Cr	20.5×	2.3×	16.1×	11.3%	13.0%	6.8%
Innova Captab Limited INNOVACAP	₹5,064 Cr	42.5×	5.5×	22.9×	12.9%	8.6%	20.7%
IOL Chemicals and Pharmaceuticals Limited IOLCP	₹4,853 Cr	28.9×	2.9×	—	10.1%	0.1%	—
Morepen Laboratories Limited MOREPENLAB	₹4,776 Cr	46.8×	3.6×	32.0×	7.6%	5.3%	8.4%

Peer comparison verdict

ONEGLOBAL looks attractively valued — trading at a discount to sector peers on P/E (14.1× vs sector median 43.8×) while delivering above-average returns on equity (401.3% vs 10.1%).

Business quality

Valuation

P/E ratio

14.1×

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

401.3%

ROCE

—

ROA

—

Growth

Revenue CAGR (3yr)

—

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

—

Dividend yield

—

Liquidity & Solvency

Debt / Equity

—

Debt / EBITDA

—

Interest coverage

—

Current ratio

—

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is unavailable for this company.

Cash flow

Where cash comes from and where it goes.

Cash flow data is not yet available for this company.

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

Balance sheet data is not yet available for this company.

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

Shareholding data is not yet available for this company.